Clinical Trial Update: IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial updating on drug dosing and outcomes for single-ventricle patients with Fontan-associated liver disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fontan Circulation
• Fontan-associated Liver Disease

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Fontan Circulation | Phase 1 | Status: RECRUITING